Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Acute and rapid degradation of endogenous proteins by Trim-Away

A Publisher Correction to this article was published on 30 November 2018

This article has been updated

Abstract

Protein depletion is a key approach to understanding the functions of a protein in a biological system. We recently developed the Trim-Away approach in order to rapidly degrade endogenous proteins without prior modification. Trim-Away is based on the ubiquitin ligase and Fc receptor TRIM21, which recognizes antibody-bound proteins and targets them for degradation by the proteasome. In a typical Trim-Away experiment, protein degradation is achieved in three steps: first, introduction of an antibody against the target protein; second, recruitment of endogenous or exogenous/overexpressed TRIM21 to the antibody–bound target protein; and third, proteasome-mediated degradation of the target protein, antibody and TRIM21 complex. Protein degradation by Trim-Away is acute and rapid, with half-lives of ~10–20 min. The major advantages of Trim-Away over other protein degradation methods are that it can be applied to any endogenous protein without prior modification; that it uses conventional antibodies that are widely available; and that it can be applied to a wide range of cell types, including nondividing primary human cells, for which other loss-of-function assays are challenging. In this protocol, we describe the detailed procedures for antibody preparation and delivery in mouse oocytes and cultured cells via microinjection and electroporation. In addition, we provide recommendations for antibody selection and validation, and for the generation of TRIM21-overexpressing cell lines for cases in which endogenous TRIM21 is limited. A typical Trim-Away experiment takes just a few hours.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3: Schematic of Trim-Away experiments in mouse oocytes.
Fig. 4: Trim-Away in mouse oocytes.

Similar content being viewed by others

Change history

  • 30 November 2018

    In the version of this paper originally published, the present address of W.A. McEwan was accidentally omitted. This address (UK Dementia Research Institute, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK) has now been added as affiliation 3, and the equal-contributions note has been updated to affiliation 4. These changes are reflected in the PDF and HTML versions of the protocol.

References

  1. Gaj, T., Gersbach, C. A. & Barbas, C. F. ZFN, TALEN and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397–405 (2013).

    Article  CAS  Google Scholar 

  2. Boettcher, M. & McManus, M. T. Choosing the right tool for the job: RNAi, TALEN or CRISPR. Mol. Cell 58, 575–585 (2015).

    Article  CAS  Google Scholar 

  3. Eisen, J. S. & Smith, J. C. Controlling morpholino experiments: don’t stop making antisense. Development 135, 1735–1743 (2008).

    Article  CAS  Google Scholar 

  4. Toyama, B. H. et al. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154, 971–982 (2013).

    Article  CAS  Google Scholar 

  5. Rao, P. N. & Engelberg, J. Mitotic duration and its variability in relation to temperature in HeLa cells. Exp. Cell Res. 52, 198–208 (1968).

    Article  CAS  Google Scholar 

  6. Weiss, W. A., Taylor, S. S. & Shokat, K. M. Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat. Chem. Biol. 3, 739–744 (2007).

    Article  CAS  Google Scholar 

  7. El-Brolosy, M. A. & Stainier, D. Y. R. Genetic compensation: a phenomenon in search of mechanisms. PLoS Genet. 13, e1006780 (2017).

    Article  Google Scholar 

  8. Banaszynski, L. A. et al. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126, 995–1004 (2006).

    Article  CAS  Google Scholar 

  9. Neklesa, T. K. et al. Small-molecule hydrophobic tagging-induced degradeation of HaloTag fusion proteins. Nat. Chem. Biol. 7, 538–43 (2011).

    Article  CAS  Google Scholar 

  10. Nishimura, K. et al. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat. Methods 6, 917–922 (2009).

    Article  CAS  Google Scholar 

  11. Caussinus, E., Kanca, O. & Affolter, M. Fluorescent fusion protein knockout mediated by anti-GFP nanobody. Nat. Struct. Mol. Biol. 19, 117–121 (2011).

    Article  Google Scholar 

  12. Robinson, M. S., Sahlender, D. A. & Foster, S. D. Rapid inactivation of proteins by rapamycin-induced rerouting to mitochondria. Dev. Cell 18, 324–331 (2010).

    Article  CAS  Google Scholar 

  13. Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl. Acad. Sci. USA 98, 8554–8559 (2001).

    Article  CAS  Google Scholar 

  14. Fan, X. et al. Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradeation. Nat. Neurosci. 17, 471–80 (2014).

    Article  CAS  Google Scholar 

  15. Clift, D. et al. A method for the acute and rapid degradation of endogenous proteins. Cell 171, 1692–1706 (2017).

    Article  CAS  Google Scholar 

  16. James, L. C. et al. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc. Natl. Acad. Sci. USA 104, 6200–6205 (2007).

    Article  CAS  Google Scholar 

  17. Mallery, D. L. et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. USA 107, 19985–19990 (2010).

    Article  CAS  Google Scholar 

  18. Watkinson, R. E. et al. TRIM21 promotes cGAS and RIG-I sensing of viral genomes during infection by antibody-opsonized virus. PLoS Pathog. 11, e1005253 (2015).

    Article  Google Scholar 

  19. McEwan, W. A. et al. Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. Proc. Natl. Acad. Sci. USA 114, 574–579 (2017).

    Article  CAS  Google Scholar 

  20. Hauler, F. et al. AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc. Natl. Acad. Sci. USA 109, 19733–19738 (2012).

    Article  CAS  Google Scholar 

  21. Fletcher, A. J. et al. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc. Natl. Acad. Sci. USA 112, 10014–10019 (2015).

    Article  CAS  Google Scholar 

  22. Tachibana-Konwalski, K. et al. Rec8-containing cohesion maintains bivalents without turnover during the growing phase of mouse oocytes. Genes Dev. 24, 2505–2516 (2010).

    Article  CAS  Google Scholar 

  23. Yoshimi, R. et al. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 182, 7527–7538 (2009).

    Article  CAS  Google Scholar 

  24. Keeble, A. H. et al. TRIM21 is an IgG receptor that is structurally, thermodynamically and kinetically conserved. Proc. Natl. Acad. Sci. USA 105, 6045–6050 (2008).

    Article  CAS  Google Scholar 

  25. Cromm, P. M. & Crews, C. M. Targeted protein degradation: from chemical biology to drug discovery. Cell Chem. Biol. 24, 1181–1190 (2017).

    Article  CAS  Google Scholar 

  26. McEwan, W. A. et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14, 327–336 (2013).

    Article  CAS  Google Scholar 

  27. Foss, S. et al. TRIM21 immune signaling is more sensitive to antibody affinity than its neutralization activity. J. Immunol. 196, 3452–3459 (2016).

    Article  CAS  Google Scholar 

  28. Bottermann, M. et al. Antibody-antigen kinetics constrain intracellular humoral immunity. Sci. Rep. 6, 37457 (2016).

    Article  CAS  Google Scholar 

  29. Smoak, E. M. et al. Long-term retention of CENP-A nucleosomes in mammalian oocytes underpins transgenerational inheritance of centromere identity. Curr. Biol. 26, 1110–1116 (2016).

    Article  CAS  Google Scholar 

  30. Conic, S. et al. Imaging of native transcription factors and histone phosphorylation at high resolution in live cells. J. Cell Biol. https://doi.org/10.1083/jcb.201709153 (2018).

  31. Jaffe, L. A. & Terasaki, M. Quantitative microinjection of oocytes, eggs, and embryos. Methods Cell Biol. 74, 219–242 (2004).

    Article  Google Scholar 

  32. Kim, J. A. et al. A novel electroporation method using a capillary and wire-type electrode. Biosens. Bioelectron. 23, 1353–1360 (2008).

    Article  CAS  Google Scholar 

  33. Freund, G. et al. Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cells. MAbs 5, 518–522 (2013).

    Article  Google Scholar 

  34. Behringer, R., Gertsenstein, M., Nagy, K. V. & Nagy, A. Preparation of media for embryo handling and culture. Manipulating the Mouse Embryo 4th edn, Ch. 4, 1 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2014).

  35. Behringer, R. et al. Making embryo-handling pipettes from hard glass capillaries. Manipulating the Mouse Embryo 4th edn, Ch. 4, Protocol 3 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2014).

  36. Schuh, M. & Ellenberg, J. Self-organization of MTOCs replaces centrosome function during acentrosomal spindle assembly in live mouse oocytes. Cell 130, 484–98 (2007).

    Article  CAS  Google Scholar 

  37. Behringer, R. et al. In vitro fertilization. Manipulating the Mouse Embryo 4th edn, Ch. 15, Protocol 2 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2014).

  38. Behringer, R. et al. Collection of zygotes and removal of cumulus cells with hyaluronidase. Manipulating the Mouse Embryo 4th edn, Ch. 4, Protocol 6 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2014).

  39. Behringer, R. et al. Collection of two-cell- to morula-stage embryos. Manipulating the Mouse Embryo 4th edn, Ch. 4, Protocol 7 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2014).

  40. Behringer, R. et al. Setting up microdrops culture. Manipulating the Mouse Embryo 4th edn, Ch. 4, Protocol 2 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2014).

  41. Borrego-Pinto, J., Somogyi, K. & Lénárt, P. Live imaging of centriole dynamics by fluorescently tagged proteins in starfish oocyte meiosis. Methods Mol. Biol. 1457, 145–166 (2016).

    Article  CAS  Google Scholar 

  42. Minaschek, G., Bereiter-Hahn, J. & Bertholdt, G. Quantitation of the volume of liquid injected into cells by means of pressure. Exp. Cell Res. 183, 434–442 (1989).

    Article  CAS  Google Scholar 

  43. Lee, G. M. Measurement of volume injected into individual cells by quantitative fluorescence microscopy. J. Cell Sci. 94, 443–447 (1989).

    PubMed  Google Scholar 

  44. Tetkova, A. & Hancova, M. Mouse oocyte isolation, cultivation and RNA microinjection. Bio-protocol 6, e1729 (2016).

    Article  Google Scholar 

  45. Clift, D. & Schuh, M. A three-step MTOC fragmentation mechanism facilitates bipolar spindle assembly in mouse oocytes. Nat. Commun. 6, 7217 (2015).

    Article  Google Scholar 

Download references

Acknowledgements

We thank A. Musacchio and S. Maffini for advice on protein electroporation, and members of the Schuh lab and the James lab for helpful discussions. The research leading to these results received financial support from the Medical Research Council (MC_U105192711 and MC_U105181010), the Max Planck Society, the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 241548, European Research Council (ERC) Starting Grant no. 337415 and a Wellcome Trust Investigator Award.

Author information

Authors and Affiliations

Authors

Contributions

D.C. and M.S. conceived and designed the study. D.C. carried out all experiments, with the following exceptions: C.S. simplified and optimized the methods for conducting Trim-Away experiments in mouse oocytes and early embryos, and optimized the peptide-binding assay. W.A.M. and D.C. optimized antibody electroporation. W.A.M. generated and characterized stable cell lines. D.C. and L.C.J. purified recombinant TRIM21 protein. C.S. and D.C. prepared figures. L.C.J. wrote the section on antibody purification; W.A.M. wrote the section on generating stable cell lines; and C.S., D.C. and M.S. wrote all other sections of the manuscript. All authors edited the manuscript. M.S. supervised the study.

Corresponding authors

Correspondence to Dean Clift, Leo C. James or Melina Schuh.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Related Link

Key reference using this protocol

1. Clift, D. et al. Cell 171, 1692–1706.e18 (2017) https://doi.org/10.1016/j.cell.2017.10.033

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clift, D., So, C., McEwan, W.A. et al. Acute and rapid degradation of endogenous proteins by Trim-Away. Nat Protoc 13, 2149–2175 (2018). https://doi.org/10.1038/s41596-018-0028-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41596-018-0028-3

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research